vTv Therapeutics (VTVT) Long-Term Debt Issuances (2017)
vTv Therapeutics' Long-Term Debt Issuances history spans 3 years, with the latest figure at $7.5 million for Q1 2017.
- For Q1 2017, Long-Term Debt Issuances changed N/A year-over-year to $7.5 million; the TTM value through Dec 2019 reached $7.5 million, changed 0.0%, while the annual FY2025 figure was $392000.0, N/A changed from the prior year.
- Long-Term Debt Issuances for Q1 2017 was $7.5 million at vTv Therapeutics, up from $13000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $10.5 million in Q2 2015 and bottomed at $13000.0 in Q3 2015.
- The 3-year median for Long-Term Debt Issuances is $8.2 million (2015), against an average of $6.9 million.
- The largest YoY upside for Long-Term Debt Issuances was 99.74% in 2015 against a maximum downside of 99.74% in 2015.
- A 3-year view of Long-Term Debt Issuances shows it stood at $9.7 million in 2014, then crashed by 99.87% to $13000.0 in 2015, then soared by 57592.31% to $7.5 million in 2017.
- Per Business Quant, the three most recent readings for VTVT's Long-Term Debt Issuances are $7.5 million (Q1 2017), $13000.0 (Q3 2015), and $10.5 million (Q2 2015).